Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Mind Medicine Inc

MNMD
Current price
6.35 USD -0.13 USD (-2.01%)
Last closed 6.31 USD
ISIN CA60255C8850
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 542 654 528 USD
Yield for 12 month -30.75 %
1Y
3Y
5Y
10Y
15Y
MNMD
21.11.2021 - 28.11.2021

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York. Address: One World Trade Center, New York, NY, United States, 10007

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

26.63 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-3 162 000 USD

Last Year

-3 223 000 USD

Current Quarter

Last Quarter

Key Figures MNMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -80 931 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -25.38 %
PEG Ratio
Return On Equity TTM -54.61 %
Wall Street Target Price 26.63 USD
Revenue TTM
Book Value 3.21 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.71 USD
Diluted Eps TTM -1.71 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics MNMD

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History MNMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:15
Payout Ratio
Last Split Date 29.08.2022

Stock Valuation MNMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -6.57
Price Book MRQ 2.07

Financials MNMD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MNMD

For 52 weeks

3.35 USD 12.22 USD
50 Day MA 6.90 USD
Shares Short Prior Month 10 054 736
200 Day MA 7.66 USD
Short Ratio 5.40
Shares Short 9 707 406
Short Percent 13.25 %